James interviewed on ****** site in last hour. Very positive results re hamsters.
A 1 log reduction is 90% reduction in viral load. 2 log is 99%. So they are looking at a reduction in high 90's.
Furthering their investigation into COVID into injected and inhaled applications.
James says they are well funded and looking forward to P1&2 burns trials in Q1 2021.
Large pharma knocking on his door. "the biggest of the big". Some of them are under CDA (confidential disclosure agreement) in early stage discussions. Having discussions from position of power. 1st new class of antibiotics for 30 years.
Above is a summary not a transcript.
Albaby
Ann: Positive Intranasal Animal Data against SARS-CoV-2 in Study, page-36
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.080(21.9%) |
Mkt cap ! $128.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 44.5¢ | 37.5¢ | $191.2K | 477.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12222 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 10976 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |